Innovating the entire procedure
The possibilities for treating patients with PAD demonstrate how far image-guided therapy has progressed in the past decade. And as we have seen, it’s not just one single imaging technology or one single bit of software that has revolutionized image-guided procedures. Rather, it is the combination of these technological advances.
Now, more than ever, I believe that the real value of solutions in image-guided therapy lies in integrating the latest imaging systems, smart devices, disease-specific software, and services – along the entire procedure. From start to finish. That is what ultimately allows image-guided therapy to deliver on the Quadruple Aim of improved patient outcomes at lower cost, with improved patient and staff experience.
For people affected by PAD, it may well make the difference between losing a foot with risk of complications or even death, and being able to walk without pain again.
 Shu, J, & Santulli, G. Update on peripheral artery disease: epidemiology and evidence-based facts. Atherosclerosis 2018; 275; 379-381
 Benoit, E, O'Donnell, TF Jr, Kitsios, GD, Iafrati, MD. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J Vasc Surg. 2012 Mar;55(3):781-9. https://www.ncbi.nlm.nih.gov/pubmed?term=22209608
 Puckridge, P., & Allan, R. IVUS sizing improves outcomes of DCB therapy in the femoropopliteal segment. Oral presentation, Charing Cross 2019, London, UK.